PTEN and cancer: Deregulated PI3K signaling in cancer has also been attributed to gain of function in receptor tyrosine kinases, activated Akt or to loss-of-function mutations in PTEN gene (Vivanco and Sawyers, 2002; Engelman et al., 2006; Yuan and Cantley, 2008).